glp-1 obesity drug updates Weight Loss Market Size, Share Study finds GLP-1 receptor agonists

Description

2021;274:E126976

The American College of Physicians recommends adding either an SGLT2 inhibitor or a GLP-1 agonist to metformin when blood sugar control is insufficient, allowing for a more tailored treatment approach

2-11 Modest reductions in weight of 5 to 10% can produce clinically significant improvements in CVD risk factors

The GLP-1 Receptor Agonist (GLP-1 RA) medications, also referred to as incretin mimetics or GLP-1 analogs, are biochemical variations of naturally occurring GLP-1 altered for enhanced potency and stability that activate GLP-1 receptors and mimic GLP-1 effects throughout the body

Opioid Use Disorder Penn State Study of Semaglutide for OUD in Combination with Methadone or Buprenorphine Status: Recruiting 200-person study of semaglutide in combination with methadone or buprenorphine